The FDA has accepted for review the resubmitted New Drug Application for reproxalap for the signs and symptoms of dry eye disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback